Abstract
In this issue of Blood, van Rhee et al report an evidence and opinion–based framework for treatment of idiopathic multicentric Castleman disease (CD), including consideration of how to assess therapeutic response and the pitfalls found in complex situations.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2109-2110 |
| Number of pages | 2 |
| Journal | Blood |
| Volume | 132 |
| Issue number | 20 |
| DOIs | |
| State | Published - Nov 15 2018 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology